| 摘要 |
<p>The invention relates to compounds of formula (I)
wherein
one of R 5 and R 6 is hydrogen or R 2 and the other is (a)
processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of conditions or disorders which are mediated via the S1P1 receptor.</p> |
